Genmab — November 2024
-
Genmab er blandt de nævnte"Analytikere: Disse fem C25-aktier ses stige over 50 pct." https://borsen.dk/nyheder/investor/analytikere-disse-fem-c25-aktier-ses-stige-over-50-pct?b_source=borsen&b_medium=row_0&b_campaign=news_3&utm_source=nyhedsbrev&utm_medium=email&utm_campaign=28.11.24-morningbrief&utm_placement=10&utm_batch=38674800402c9db#newsletter
-
Ud fra kurshistorikken, så kunne de bare ændre titlen for Genmabs vedkommende til 100 pct.
-
Genmab/SHB: Skærer kursmål og gentager "market perform" https://proinvestor.com/investornyt/1248292/genmab-shb-skaerer-kursmal-og-gentager-market-perform
-
Børsen - FEM C25-AKTIER SES STIGE OVER 50 PCT.
Analytikerne peger på fem C25-aktier med særligt stort kurspotentiale efter den danske regnskabssæson. Det er Vestas, GN Store Nord, Torm, Bavarian Nordic og Genmab. (Side 37)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind